Last night around 3 A.M. I listened to an audio with Dr. Nicholas Gonzales.

He talked about the origins of chemotherapy (leftover nerve gas from World War I), and detailed his protocol for healing even stage 4 cancers. NUTRITION is, of course, a huge part of it. Also learned something new: he said that blood-based cancers, namely leukemia and Hodgkins (and lympthoma?) actually do benefit from chemo (at least until you take into account their inevitable pernicious side effects), but that no other cancers do. And, I’m happy to say that he pointed out that oncologists make money from the chemo drugs they order wholesale and prescribe retail. Nobody notices, since insurance companies usually pay.

The nerve gas connection reminds me of the explosives connection in the origin of pesticides for food crops. In both cases, something developed to destroy people in war, made to perform other — peaceful? no; poisonous — functions. I.e., war, by other means — slow, invisible and insidious.

After listening to the audio, I discovered that this alternative doctor has also died, on July 21, one of many in recent months. What’s going on?

Here’s Mike Adams, who investigates the Jeffrey Bradstreet murder.

INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF

But see snopes.com. Who or what to “believe” in this mad mad age?

I imagine Adams will also investigate the more recent death of Dr. Gonzales.

If anyone still wonders why NOT curing cancer is a big deal for the Medical Industrial Complex, here’s Mike Adams, speaking truth to power:

Is there a motive for the murder of pioneering cancer researchers working on a possible universal cancer cure? Of course there is… it’s the most common motive in the world: MONEY.

A universal cancer cure would destroy the profitability of the highly lucrative cancer industry and collapse the American Cancer Society, hospitals, oncology clinics and pharmaceutical companies that depend on chemotherapy revenues to stay profitable. Key to their profitability is the inescapable fact that conventional cancer treatments simply don’t work most of the time, creating a reliable profit stream of repeat business from patients who are never cured (by design).